If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
112.00    -2.00 (-1.75%)
Bid:
109.00
Ask:
112.50
Spread: 3.50 (3.211%)
Market Cap: £110.38m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Acquisition

9 Mar 2016 07:00

RNS Number : 4738R
Eurocell plc
09 March 2016
 

9 March 2016

 

Eurocell plc

Acquisition of Vista Panels Ltd

 

Eurocell plc ("Eurocell" or the "Company"), the leading sustainable B2B supplier of PVC building products with its own distribution network is pleased to announce it has signed an agreement for the acquisition of Vista Panels Ltd ("Vista") from CorpAcq Limited. The consideration for the acquisition is £7.1m, on a debt free, cash free basis, to be funded from existing bank facilities and is expected to be earnings enhancing in the first full year of ownership.

About Vista

Headquartered in the Wirral, United Kingdom, Vista is a leading manufacturer of composite and PVC-U entrance doors and has been a leader in the growth of the composite doors market in the UK, with a strong presence in the social housing and private RMI sectors. It is currently the sole supplier of entrance doors to Eurocell and a significant consumer of Eurocell's profile products. The Company currently employs over 100 people nationwide. In the year ended 31 December 2015, Vista generated revenue of £13.7m. The earnings before interest and tax were £1.4m and gross assets were £3.9 million.

It is expected that Vista will continue to operate as a standalone business in the Wirral under the Vista brand. The current management team will remain with Vista.

Patrick Bateman, Chief Executive Officer, commented: "The acquisition will broaden the routes to market for Vista in particular to the new build sector, and provide opportunity for cross selling into the respective customer bases. We know the business well, having worked with them both as a customer and a supplier. It's logical, therefore, that we wanted them to join forces with us. Together we have a stronger proposition in markets strategically important to both businesses." 

 

Enquiries:

Teneo Strategy +44 (0) 20 3603 5220

Ben Foster

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQSSEEFAFMSEED
Date   Source Headline
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
24th Aug 20163:41 pmRNSDirector/PDMR Shareholding
23rd Aug 20167:00 amRNSHalf Year Results
21st Jul 20163:12 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSAwards to Directors and PDMRs
19th May 20162:43 pmRNSResult of AGM
19th May 20167:00 amRNSAGM Trading Update
21st Apr 20166:04 pmRNSHolding(s) in Company
20th Apr 20167:00 amRNSResult of Placing
19th Apr 20164:36 pmRNSProposed Placing
7th Apr 20163:58 pmRNSConfirmation of CEO Board Change
16th Mar 20167:00 amRNS2015 Full Year Results
9th Mar 20167:00 amRNSAcquisition
26th Jan 20167:04 amRNSDirectorate Change
21st Jan 20167:00 amRNSTrading Statement
1st Dec 20153:06 pmRNSHolding(s) in Company
11th Nov 201510:56 amRNSDirector Declaration
18th Sep 20159:56 amRNSHolding(s) in Company
17th Sep 201511:31 amRNSHolding(s) in Company
17th Sep 201511:29 amRNSHolding(s) in Company
15th Sep 201511:06 amRNSResult of Placing
15th Sep 20157:00 amRNSProposed Placing
25th Aug 20157:00 amRNSHalf Yearly Results
29th May 20152:59 pmRNSChange of Adviser
13th May 20155:32 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSAppointment of Joint Corporate Brokers
11th Mar 20154:33 pmRNSHolding(s) in Company
11th Mar 20153:17 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSAnnouncement of Grant Awards
9th Mar 20158:00 amRNSAdmission to Trading on London Stock Exchange
4th Mar 20152:31 pmRNSPublication of Prospectus
4th Mar 20157:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.